MEDPACE HOLDINGS INC (MEDP) Stock Analyst Ratings
USA - NASDAQ:MEDP - US58506Q1094 - Common Stock
590.18 USD
+4.42 (+0.75%)
591.66 USD
+1.48 (+0.25%)
ChartMill assigns a Buy % Consensus number of 52% to MEDP. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 519.85. This target is -11.92% below the current price.
MEDP was analyzed by 17 analysts. The buy percentage consensus is at 52. So analysts seem to be rather neutral about MEDP.
In the previous month the buy percentage consensus was at a similar level.
MEDP was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-13 | BMO Capital | Initiate | Market Perform |
| 2025-10-24 | TD Cowen | Maintains | Sell -> Sell |
| 2025-10-24 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-10-24 | Barclays | Maintains | Underweight -> Underweight |
| 2025-10-17 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-10-02 | Barclays | Downgrade | Equal-Weight -> Underweight |
| 2025-09-09 | Jefferies | Maintains | Hold -> Hold |
| 2025-09-03 | Rothschild & Co | Downgrade | Buy -> Neutral |
| 2025-07-29 | UBS | Downgrade | Neutral -> Sell |
| 2025-07-25 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-07-23 | TD Cowen | Downgrade | Hold -> Sell |
| 2025-07-23 | Deutsche Bank | Maintains | Hold -> Hold |
| 2025-07-23 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-23 | Truist Securities | Maintains | Hold -> Hold |
| 2025-07-23 | Baird | Maintains | Neutral -> Neutral |
| 2025-06-24 | Barclays | Initiate | Equal-Weight |
| 2025-04-23 | Truist Securities | Maintains | Hold -> Hold |
| 2025-04-23 | Baird | Maintains | Neutral -> Neutral |
| 2025-04-22 | William Blair | Downgrade | Outperform -> Market Perform |
| 2025-04-14 | TD Cowen | Downgrade | Buy -> Hold |
| 2025-04-10 | Truist Securities | Maintains | Hold -> Hold |
| 2025-04-09 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-03-24 | Leerink Partners | Initiate | Market Perform |
| 2025-01-27 | Baird | Maintains | Neutral -> Neutral |
| 2024-11-25 | Baird | Maintains | Neutral -> Neutral |
| 2024-10-23 | TD Cowen | Maintains | Buy -> Buy |
| 2024-10-23 | Baird | Downgrade | Outperform -> Neutral |
| 2024-10-22 | William Blair | Reiterate | Outperform |
| 2024-10-14 | Redburn Atlantic | Initiate | Buy |
| 2024-10-14 | Truist Securities | Maintains | Hold -> Hold |
MEDPACE HOLDINGS INC / MEDP FAQ
Can you provide the average price target for MEDPACE HOLDINGS INC stock?
17 analysts have analysed MEDP and the average price target is 519.85 USD. This implies a price decrease of -11.92% is expected in the next year compared to the current price of 590.18.
What is the consensus rating for MEDPACE HOLDINGS INC (MEDP) stock?
The consensus rating for MEDPACE HOLDINGS INC (MEDP) is 51.7647 / 100 . This indicates that analysts generally have a neutral outlook on the stock.